Illumina Settles DNA Patent Row With Enzo For $21M
Illumina Inc. has agreed to pay $21 million to Enzo Life Sciences Inc. to settle a long-standing infringement suit in Delaware federal court, the latest in a string of sizable settlements...To view the full article, register now.
Already a subscriber? Click here to view full article